Hypha Labs, Inc.
FUNI
$0.0247
-$0.0001-0.40%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -52.56% | 159.61% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -52.56% | 159.61% | |||
| Operating Income | 52.56% | -159.61% | |||
| Income Before Tax | 52.09% | -180.37% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 52.09% | -187.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.09% | -187.47% | |||
| EBIT | 52.56% | -159.61% | |||
| EBITDA | 52.66% | -159.79% | |||
| EPS Basic | 54.63% | -176.92% | |||
| Normalized Basic EPS | 53.03% | -144.44% | |||
| EPS Diluted | 7.41% | -176.92% | |||
| Normalized Diluted EPS | 53.03% | -144.44% | |||
| Average Basic Shares Outstanding | 5.19% | 5.09% | |||
| Average Diluted Shares Outstanding | 5.19% | 5.09% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||